N4-(3-Bromophenyl)quinazoline-4,6-diamine
| Title | Journal |
|---|---|
| Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides. | Journal of medicinal chemistry 20120308 |
| Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents. | European journal of medicinal chemistry 20120301 |
| The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase. | Bioorganic & medicinal chemistry 20110815 |
| The combi-targeting concept: selective targeting of the epidermal growth factor receptor- and Her2-expressing cancer cells by the complex combi-molecule RB24. | The Journal of pharmacology and experimental therapeutics 20100701 |
| Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion. | Journal of medicinal chemistry 20100311 |
| N-(3-Bromo-phen-yl)quinazoline-4,6-diamine. | Acta crystallographica. Section E, Structure reports online 20100201 |
| Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging. | European journal of medicinal chemistry 20091001 |
| Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. | Nature chemical biology 20070401 |
| The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR). | Journal of medicinal chemistry 20060615 |
| Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a novel tumor targeting concept. | Journal of medicinal chemistry 20031204 |
| The combi-targeting concept: chemical dissection of the dual targeting properties of a series of 'combi-triazenes'. | Journal of medicinal chemistry 20030925 |
| 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. | Journal of medicinal chemistry 20010816 |
| Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor. | Journal of medicinal chemistry 19970606 |
| Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. | Journal of medicinal chemistry 19960105 |